Abstract. Breast cancer is one of the most common cancers in women and it is highly treatable by radiotherapy and/or radiochemotherapy. A global analysis of the protein expression pattern was performed to identify radiation-responsive proteins in MCF-7 breast cancer cells using 2D-PAGE coupled with MALDI-TOF-MS. When MCF-7 cells were exposed to ionizing radiation (IR) such as γ-rays, eight proteins (GH2, RGS17, BAK1, CCNH, TSG6, RAD51B, IGFBP1, and CASP14) were up-regulated and three proteins (C1QRF, PLSCR2, and p34 SE1-1 ) were down-regulated. In an effort to find what mechanisms are responsible for these changes, we initially focused on p34 SE1-1 , which is known as a transcriptional regulator and oncogene. Our results show that p34 SE1-1 expression is significantly decreased only at the protein level but not at the transcriptional level after IR treatment. We suggest that the B55 regulatory subunit of PP2A, a positive regulator of p34 SE1-1 , is at least partly responsible for the decreased p34
Introduction
Breast cancer is a common malignancy worldwide and is a leading cause of death in women over the world. Radiotherapy is generally used in conjunction with chemotherapy, hormonetherapy, or surgery. Radiotherapy is considered as an important treatment of cancer as it can be used to treat most common types of cancer to some extent. Radiation is known to activate multiple signaling pathways for cancer cells to be inactivated, resulting in diverse stress responses including apoptosis, cell cycle arrest, senescence, and gene induction. Many aspects of the initial response to radiation-induced DNA damage have been extensively analyzed via p53 and other DNA damage checkpoint responses (1, 2) . Although several mechanisms are known to be involved in these processes, the molecular mechanisms inactivating tumor cells in response to radiation is not yet fully elucidated. Moreover, many tumors fail to respond to radiotherapy because the tumors have become less sensitive and more resistant to it after constitutive treatments. Although many studies on the molecular mechanisms of resistance to radiotherapy have been carried out, problems related to overcoming this resistance remains to be solved. Therefore, it will be helpful to identify radiation-responsive genes to better understand the molecular mechanisms involved in the response of tumors to radiation and ultimately to improve radiotherapy. Many radiation-responsive genes have been identified through different approaches. Among them, stress-responsive effector genes are known to be inducible by radiation, and their products participate in the radiation induced response (3) (4) (5) . The major radiation-responsive effector genes include RAF1, p21, p53, GADD45A (GADD45), 14-3-3 sigma, BAX, TNFRSF (Fas/APO1), TNFRSF 10B (KILLER/ DR5), PIG3, THBS1 (TSP1), IGFBP3, and DIR1 (6) (7) (8) (9) . They play key roles in the cellular response to radiation-induced stress by modulating cell cycle checkpoints, apoptosis, and DNA repair (3-4,10-13). Kis et al identified another set of radiationresponsive genes using microarray analysis in primary human fibroblasts (14) . They detected about 200 IR responsive genes at the transcriptional level, in which 30 genes (28 up-and 2 down-regulated) responded to radiation in all investigated cells and 20 were functionally grouped. They belong to one of the following groups: the DNA damage response (GADD45A, BTG2, PCNA, and IER5), regulation of cell cycle and cell proliferation (CDKN1A, PPM1D, SERTAD1, PLK2, PLK3,
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SEI-1 expression in response to ionizing radiation in MCF-7 human breast cancer cells and CYR61), programmed cell death (BBC3 and TP53INP1), signaling pathways (SH2D2A, SLIC1, GDF15, and THSD1), and other functions (SEL10, FDxR, CYP26B1, and OR11A1) (14) . However, the mRNA expression profiles did not match up to their protein expression profiles because radiationresponsive genes seem to respond differently at the transcriptional and the protein levels.
The objective of the present study was originally aimed to identify the radiation-responsive genes at the protein levels in MCF-7 human breast cancer cells using the 2D-PAGE and MALDI-TOF-MS. In this process, we observed that the expression level of p34 SEI-1 oncogene, one of the differently expressed proteins, was down-regulated at the protein level by the inhibition of PP2A phosphatase enzyme activity after being exposed to IR.
Materials and methods

Condition of MCF-7 cell culture and treatment of IR, H 2 O 2 , and okadaic acid (OA).
The MCF-7 human breast cancer cell line was purchased from the American Type Culture Collection (ATCC, USA). MCF-7 cells were cultured at 37˚C in a humidified atmosphere composed of 95% air and 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM) media (WelGENE, Korea). This medium was supplemented with 10% fetal bovine serum (Gibco-BRL, Korea) and 1% antibioticantimycotic (Gibco-BRL). To induce an IR response, the MCF-7 cells were irradiated with γ-rays with a 137 Cs γ-ray source (Atomic Energy of Canada, Ltd., Ontario, Canada) and harvested after indicated times of incubation at 37˚C for further experiment. The MCF-7 cells were also cultured in a medium containing different concentrations of H 2 O 2 (Sigma, Korea) as indicated. To inhibit the enzyme activity of PP2A protein phosphatase, the MCF-7 cells were treated with 0.1 mM of OA, which was purchased from LC Labs (Cat No. O-2220, USA) and dissolved in dimethyl sulfoxide (DMSO, Sigma, Korea).
Protein extraction. Cells were harvested and washed twice with cold PBS (phosphate-buffered saline) buffer and centrifuged at 3,000 rpm, 4˚C for 3 min. The supernatant was removed and then the cells were resuspended with lysis buffer [500 mM HEPES (pH 8.5), 4% CHAPS, 8 M urea, 1 µg /ml aprotinin, 100 µg/ml PMSF, and 2.4 mg/ml DTT], sonicated for 10 sec on the ice, centrifuged at 13,000 rpm, 4˚C for 10 min, and then harvested.
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE)
, gel scanning, and image analysis. The first dimensional isoelectric focusing (IEF) was performed on precast 18 cm immobilized pH 3-10 gradient (IPG) strips (Amersham Pharmacia Biotech) at 20˚C using a commercial flatbed electrophoresis system (IPGphor; Amersham Pharmacia Biotech). The total proteins of 500 µg were mixed with a rehydration buffer containing 8 M urea, 2% (w/v) CHAPS, 2.4 mg/ml DTT, 2% (v/v) IPG buffer, and a trace of bromophenol blue for the tracking dye. The mixtures were loaded onto the IPG strip, followed by 12 h of active rehydration at 50 V, 50 µA and ramped to 500 V, 50 µA over a period of 10 min and then kept at 5,000 V, 50 µA for 1 h. At the end of the first dimension run (80 kV·h), the IPG strips were immediately loaded onto 11% SDS-PAGE gels and held in place with 0.5% agarose dissolved in a SDS-PAGE running buffer. In the second dimension, the SDS-PAGE was performed for separation without a stacking gel at 150 V, 20 mA for about 20 h per gel in an SDS-electrophoresis buffer (25 mM Tris, 92 mM glycine, and 0.1% SDS). After the electrophoresis separation, the gels were stained by silver-staining. The stained 2-D gels were scanned on a Las-3000 (Fuji Photo Film Co.) by using the 2-D software PDQuest (Bio-Rad). The different gel patterns were then automatically matched to each other and the quantities of matched spots in different gels were compared. The molecular masses and pI were calculated by the PDQuest software using the selected pI and Mr standard proteins.
Matrix assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS).
Proteins from gels were identified by mass spectrometry (MALDI-TOF). After tryptic in-gel digestion of 2D-PAGE resolved proteins, samples for MALDI peptide mass mapping were prepared as described previously (15) . Mass spectra were obtained using Voyager-DE STR MALDI-TOF mass spectrometer (Applied Biosystems, Cambridge, MA). Proteins were identified according to their tryptic peptide mass fingerprint after database searching performed the MS-Fit, which is accessible over World Wide Web at http://prospector.ucsf.edu/. MS-Fit performed fast database search by comparing experimentally determined masses from proteolytic digestion of protein with peptide database masses calculated from NCBlnr protein database and SWISS-PROT accession numbers.
Cell cycle analysis by fluorescence-activated cell sorting (FACS).
For FACS analysis, cells were harvested at the indicated time points, washed twice in ice-cold PBS buffer, and fixed by resuspending them in absolute ethanol for 30 min. The fixed cells were centrifuged at 1,500 rpm for 5 min and washed twice with cold PBS buffer. The cell pellets were resuspended in 0.5 ml PBS containing 50 µg/ml propidium iodide (Sigma-Aldrich Chemical Co., Korea), 10% sodium citrate (Sigma), 100 µg/ml RNase (Invitrogen, Korea), and 0.001% NP40 (Sigma). Following the incubation at 37˚C for 30 min in the dark, the samples were analyzed by a FACScan flow cytometer (Becton-Dickinson FACScan, Sunnyvale, CA, USA) equipped with CellQuest 3.2 software (BectonDickinson).
Western blot analysis. The cells were centrifuged at 3,000 rpm for 3 min and washed twice in an ice-cold PBS buffer. The cells were then lysed in EBC lysis buffer and the protein amount was quantified using a protein assay kit (Bio-Rad). Approximately 15 µg of total protein per sample was subjected to SDS-PAGE and transferred to an Immobilon polyvinylidene difluoride filter (Millipore). The filter was blocked in 5% non-fat dry milk/0.1% Tween/TBS followed by incubation with each corresponding antibody and immunodetection was done using the ECL System (Amersham Pharmacia Biotech). Antibodies used in this study were purchased as follows: p34 SEI-1 (Enzo Life Sciences, ALx-804-645), PP2A-B55 (Santa Cruz, sc-18330), p-Chk1(Ser345) (Cell Signaling, no. 2341), and γ-tubulin (Santa Cruz, sc-7396).
Reverse transcription (RT)-PCR.
The total RNA was extracted from MCF-7 cells using the RNeasy Minikit (Qiagen). For reverse transcription, one µg RNA of each sample was subjected to cDNA synthesis using an oligo (dT) primer and the Revert Aid First Strand cDNA Synthesis kit (Fermentas, Korea) following the manufacturer's instructions. PCR amplification was performed using 10 ng cDNA, different sets of primers, and AccuPower PCR PreMix (Bioneer, Korea). The 142-bp of p34 SEI-1 gene products were amplified with p34 SEI-1 -RT-F (5'-ACATTGAGGGCCTGAGTCAG-3') and p34
SEI-1 -RT-R (5'-TCAAGCCCATCGTCCAGTAG-3') primers at 72˚C for 27 cycles. As an internal control, the 377-bp of β-actin gene products were generated using pACTB-RT-F (AGGTCGGAG TCAACGGATTTG) and pACTB-RT-R (GTGATGGCATG GACTGTGGT) primers at 58˚C for 21 cycles. The amplification reaction was carried out using the GeneAmp PCR System 9700 from Applied Biosystems. The amplification products were electrophoresised on a 2% agarose gel stained with ethidium bromide and visualized in a LAS-3000 imaging system.
Results
G2 cell cycle arrest induced by IR in MCF-7 cells.
We initially exposed the MCF-7 breast cancer cells to various γ-ray doses of 1, 5, 10, or 20 Gy. Cell growth was repressed in the 20 Gy radiation treated cells as shown in Fig. 1A . IR treatment of the MCF-7 cells did not affect cell viability as assessed by the trypan blue exclusion test (data not shown). Instead, the cell growth was repressed due to cell cycle arrest at the G2 phase as revealed in FACS analysis (Fig. 1B) . This result implies that IR irradiated MCF-7 cells undergo cell cycle arrest rather than apoptosis. The data are consistent with a previous study that IR induces cell cycle arrest but fails to activate the mitochondrial death pathway in MCF-7 cells (16) . Then, our curiosity about what genes are responsible for this phenotype prompted us to identify the radiation-responsive genes in MCF-7 cells.
Identification of p34
SE1-1 as a radiation-responsive gene in MCF-7 cells. To identify radiation-responsive genes, MCF-7 breast cancer cells were irradiated with 20 Gy of γ-rays and harvested after incubation for 12, 24, and 48 h. We then observed differentially expressed proteins using 2D-PAGE and MALDI-TOF-MS as described in Materials and methods. Proteins of about 1,000 to 1,200 spots in each gel were visualized by silver staining and detected by PDQuest 2D-image-analysis software (Bio-Rad). After spot detection, the gels were matched to each other with the help of the so-called landmark function and about 730 spots in total were matched in all gels analyzed according to PDQuest software. For internal standards, 9 spots were chosen randomly to calculate the deviation of the spot position and identified by MALDI-TOF-MS. These identified proteins include LMNA, PPP3CA, HNRPH3, CA13, BTEB1, SCN3B, ZFx, PPIA, and C20ORF179. They were used for the generation of a relevant pI and Mr scale for the whole pattern. When the expression patterns of proteins were compared with the control gel, many spots were found to differ greatly. Among them, 11 spots were found to be significantly different. One set of proteins were up-regulated in response to IR in MCF-7 cells. They include GH2, RGS17, BAK1, CCNH, TSG6, RAD51B, IGFBP1, and CASP14. More information is listed in Table I . Most of these proteins are known to be involved in the cellular processes of cell cycle control, apoptosis, DNA repair, cell proliferation, and other functions. In another set, the expression levels of three proteins were down-regulated after the exposure of γ-rays. They include C1QRF, PLSCR2, and p34 SE1-1 . p34 SE1-1 , the subject of this report, encodes a cycline-dependent kinase 4 (cdk4)-binding protein. It is identical to the TRIP-Br1 (transcriptional regulator interacting with the PHD-bromodomain 1) and SERTAD1 (SERTA domain containing 1). A considerable amount of p34 SE1-1 was detected in the control gel (0 h). However, the expression level of p34 SE1-1 started to decrease from 12 h and significantly down-regulated after 48 h (Fig. 2) . The regions containing p34
SE1-1 are marked by black rectangles and magnified on the lower gels. It is known that p34 SE1-1 functions in both the transcriptional regulation and cell cycle progression working with the E2F1/DP1 transcription complex. It positively regulates the cell cycle progression by rendering the activity of Cyclin D/CDK4 (Cyclin dependent kinase 4) resistant to the inhibitory effects of p16
INK4a after forming a stable quaternary complex with Cyclin D, CDK4, and p16
INK4a (17) (18) (19) (20) . In addition, the p34 SE1-1 functions as an onco-protein in cells as The horizontal axis is the isoelectric focusing dimension, which stretches from pH 3 (left) to pH 10 (right). The vertical axis is the polyacrylamide gel dimension, which stretches from 10 kDa (bottom) to 100 kDa (top). In the upper panels, protein expression patterns are shown from the left of top. The regions containing p34 SE1-1 protein are indicated with the black rectangles. In the lower panels, p34 SE1-1 protein is indicated with the arrows on the enlarged gels, which shows the difference more clearly.
shown in recent studies. For example, p34 SE1-1 is able to induce oncogenic transformation of mouse fibroblasts (21) . The p34 SE1-1 gene is also found to be highly expressed in carcinomas from pancreatic, lung, and ovarian tissues (17, 22, 23) . Our previous study showed that p34 SE1-1 expression is absent or weak in normal tissues but is strongly expressed in tissues obtained from patients with breast cancer, in which the antiapoptotic function of p34 SE1-1 increases tumor cell survival by protecting the x-linked inhibitor of apoptosis protein (xIAP) from degradation (24) .
In addition to these well known facts about p34 SE1-1 , our data imply that the p34 SE1-1 protein may also be involved in the IR induced tumor cell inactivation. In other words, IR leads to the loss of the oncogenic function of p34 SE1-1 through a decrease in the p34 SE1-1 protein level and inactivates tumor cells.
Decreased p34 SE1-1 expression at the protein level but not at the transcriptional level. Our 2D-PAGE result suggests that IR exerts a negative effect on the p34
SE1-1 expression at the protein level. This was further tested using a Western blot analysis. MCF-7 cancer cells were irradiated with 20 Gy of γ-rays and then harvested after incubation for 4, 24, 48, and 72 h.
The level of p34
SE1-1 protein was significantly decreased after 48 h compared to IR non-treated cells (Fig. 3A) . Radiationinduced phosphorylation of Chk1 at Ser345 causes p53-dependent cell cycle arrest at the G2 phase (25) . Therefore, phosphorylated Chk1 at Ser345 [p-Chk1(Ser345)] was used as a positive control. Discovery of the inverse relationship between γ-ray treatment and the p34 SE1-1 protein level suggested the possibility of the same situation at the transcriptional level. To test the hypothesis, the total RNA was isolated from the MCF-7 cells after the exposure to IR as indicated in Materials and methods. The transcriptional level of the p34 SE1-1 gene was measured using RT-PCR. Our result shows that radiationinduced transcriptional down-regulation was not detected in the p34 SE1-1 gene expression (Fig. 3B) . Taken together, IR affects p34 SE1-1 expression only at the protein level not at the transcriptional level.
Effect of IR-induced PP2A inactivation on p34
SEI-1 expression.
The next question was what mechanism is responsible for the decreased p34
SE1-1 expression after exposure to IR. Zang et al recently suggested that inhibition of PP2A activity increases the accumulation of phosphorylated p34
SEI-1 (p34 SEI-1 -SerP) with low stability and finally decreases the total amount of p34 SE1-1 protein (26). PP2A-ABαC interacts with p34 SE1-1 and dephosphorylates p34 SE1-1 in the cytoplasm (26) . In eukaryotic cells, PP2A is an essential serine/threonine phosphatase that regulates a variety of key steps in metabolism, replication, transcription, translation, metabolism, cell cycle progression, cell division, and apoptosis (27) (28) (29) . PP2A consists of a 65-kDa scaffolding subunit (A), a 36-kDa catalytic subunit (C), and one of a variety of regulatory subunits that belong to four different families of unrelated proteins (e.g. B, B' , B'' , and B'''). These regulatory subunits control the localization and specific activity of different ABC heterotrimers within cells by directing the phosphatase activity to different substrates. Among various regulatory subunits, Zang et al showed that especially the B regulatory subunit is responsible for the p34 SE1-1 stability (26). It is also well known that IR-induced multiple signaling pathways are controlled by phosphorylation and dephosphorylation of serine and threonine residues in proteins, which is mediated by different kinds of Ser/Thr kinases and phosphatases. For example, IR inactivates heterotrimeric PP2A in an ataxia telangiectasia-mutated (ATM)-dependent and wortmanninsensitive manner causing the activation of cell cycle checkpoints (30, 31) .
These facts implied that PP2A might be responsible for the decreased p34 SEI-1 expression in response to IR. Among many regulatory subunits, especially the B55 regulatory subunit unit was considered to be responsible for this mechanism. This assumption was based on the fact that IR has a negative effect especially on the B55 subunit but not on the B56 regulatory subunit. This hypothesis was at first tested by measuring the protein level of the B55 regulatory subunit of PP2A (PP2A-B55) and p34 SEI-1 after the cells were exposed to IR. The level of the PP2A-B55 subunit was down-regulated to a great degree after the exposure to IR. It was followed by a decrease in the total amount of p34 SEI-1 protein (Fig. 4A) . Therefore, we concluded that inactivated PP2A due to the absence of the PP2A-B55 regulatory subunit no longer exerted a positive effect on the p34 SEI-1 expression. This conclusion was supported by using OA, potent inhibitor of PP2A. The p34 SEI-1 protein level was measured in the presence or absence of 0.1 mM of OA. The MCF-7 cells were treated with OA for 4, 8, 16 and 24 h. The level of p34 SEI-1 protein did not change until 8 h but started to decrease from 16 h (data not shown).
The p34
SEI-1 protein level was significantly down-regulated at 24 h (Fig. 4B) .
Taken together, our result suggests that IR-induced loss of PP2A-B55 seems to be responsible for the down-regulation of p34 SEI-1 protein in MCF-7 cells.
Effect of hydrogen peroxide (H 2 O 2 ) on p34
SEI-1 expression in MCF-7 cells. Both IR and H 2 O 2 belong to reactive oxygen species (ROS) producing DNA damage through reactive oxygen intermediates (32) . Accordingly, we expected that (Fig. 5A ). The treatment of concentrations higher than 0.8 mM H 2 O 2 caused cell death (Fig. 5B ). Cells treated with 0.4 mM H 2 O 2 were subjected to cell .cycle arrest at both G1 and G2, which was different from that of IR (Fig. 5C) SEI-1 gene was measured at the protein and transcriptional levels using Western blotting and RT-PCR, respectively. Unexpectedly, no significant change in p34 SEI-1 expression was detected at either level (Fig. 5D ). This result implies that MCF-7 cells seem to use different signaling pathways in response to IR and H 2 O 2 stresses although both of them belong to the same DNA damage-inducing stimuli of reactive oxygen species (ROS).
Discussion
In the process of identifying radiation-responsive proteins, our results showed that the level of p34 SEI-1 expression was decreased in response to IR at the protein level but not at the transcriptional level. The p34 SEI-1 expression is down-regulated at least partly due to the inhibition of PP2A phosphatase activity, which results from a decreased B55 regulatory subunit. Our result implies that the p34 SE1-1 protein level is strongly affected by phosphorylation and dephosphorylation on protein. In an effort to find the dephosphorylatin site on the p34 SE1-1 protein, we tried to identify the possible Ser/Thr protein kinase involved in the phosphorylaion of the p34 SE1-1 protein by using the TRANSFAC database (http://www.genome.ad.jp). Our protein sequence-based analysis revealed seven putative binding sites of two kinds of Ser/Thr protein kinases, six serine residues in Casein kinase II (CKII) binding motifs and one threonine residue in protein kinase C (PKC) binding motifs in the p34 SE1-1 protein (Fig. 6) . CKII has been implicated in cell cycle control, DNA repair, regulation of the circadian rhythm, and other cellular processes. PKC controls the function of other proteins in many cellular processes. However, it was proposed that p34 SE1-1 is phosphorylated only on serine but not on threonine residue (26) . Therefore, PKC appears not to be a possible kinase for phosphorylation of the p34 (33) . CDK2 (cyclin dependent kinase 2) also belongs to the Ser/Thr protein kinase superfamily. CDK2 activated by CyclinA plays a critical role in the control of the cell cycle at the G1/S (start) and G2/M (mitosis) transitions.
It has been suggested that p34 SE1-2 (TRIP-Br2) can exist in a serine-phosphorylated form in cells. Phosphorylated p34
SE1-2
is then translocated from the nucleus into the cytosol by the CRM1-mediated nuclear export machinery and targeted to be degraded by 26 proteasome (34) . Considering that the p34
SE1-1
belongs to the same family as p34 SE1-2 , it is plausible to assume that the p34 SE1-1 expression may be regulated in a similar manner. In fact, our protein analysis revealed three putative CRM1 binding sites in the amino acid sequences of p34 SE1-1 protein (Fig. 6 ). CRM1 directs nuclear export of target proteins via direct binding to the leucine-rich nuclear-export signals (NES consensus) of amino acids (35, 36) . Based on all known facts and our study, we propose a model of the regulation of PP2A on p34
SEI-1 expression in response to IR. Nuclear p34
forms a complex with the E2F1/DP-1 transcriptional factors close to E2F-responsive promoters. The complex induces E2F-mediated transcription for proper G1/S transition. Phosphorylation of the E2F1/DP-1/p34 SEI-1 transcriptional complexes by cyclin A/CDK2 or yet-unknown kinase(s) may lead to their release from E2F-responsive promoters.
Dissociated p34
SEI-1 may be targeted for ubiquitination by unknown ubiquitin ligase(s). Polyubiquitinated p34 SEI-1 may be recognized by the CRM1-mediated nuclear export machinery as the case of p34 SE1-2 and thus eventually exported to cytosol, where the polyubiquitinated p34 SEI-1 maybe targeted to the 26S proteasome for proteolysis. In this process, if phosphorylated p34 SEI-1 is dephosphorylated by PP2A, p34 SEI-1 may not be degraded by proteasome. However, if cells are exposed to IR, PP2A will be inactivated because of the decreased PP2A-B55 regulatory subunit. Therefore, p34
SEI-1 is no longer a dephosphorylated stable form and therefore expression of SEI-1 is down-regulated in response to IR. Our study leads to the question whether IR induced G2 cell arrest has a direct relatioship with decreased levels of p34 SE1-1 and PP2A-B55. Although substantial indirect and direct evidence points to the key roles of p34 SE1-1 and PP2A in cell cycle regulation, the control of the enzyme activities prior to and after the transition are not fully clarified. Considering the important roles of p34 in cell cycle regulation at the G2 phase as well as the G1/S phase, we speculate that nonfunctional p34
SE1-1 and PP2A-B55 may not be able to normally regulate the cell cycle and therefore they may be at least in part related to G2 cell cycle arrest in response to IR.
In conclusion, our findings suggest that alleviating the positive effect of PP2A-B55 on p34
SEI-1 oncogene could contribute to developing of more effective ways of combining radiation therapy with other systemic therapies. Moreover, this study will be helpful to better understand the molecular mechanism that responds to radiation in cancer cells.
